Detalles de la búsqueda
1.
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS).
Int J Clin Pract
; 71(5)2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28508460
2.
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study.
Lung Cancer
; 124: 310-316, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30119925
3.
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Lung Cancer
; 124: 298-309, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29961557
4.
Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma.
Sarcoma
; 2017: 2372135, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512389
5.
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study).
Melanoma Res
; 27(6): 607-618, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28800027
6.
Cost Effectiveness Analysis of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Spain: Management in the Later Line of Therapy.
J Health Econ Outcomes Res
; 3(2): 180-193, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-37663315
7.
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea.
Clinicoecon Outcomes Res
; 8: 485-493, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698565
Resultados
1 -
7
de 7
1
Próxima >
>>